The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Factor Assays specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the Factor Assays closer to the patient, creating additional opportunities and challenges for suppliers.

This report presents supplier shares and segment forecasts for Factor Assays performed in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.